Treat‐to‐target implementation in rheumatoid arthritis (RA) requires a shared decision making (SDM) process. However, ability to pay is a major determinant of patient choice, but how this factor affects SDM is under explored. You can request a copy of this article by replying to this email. Please be clear which article you are requesting.